MAR 18, 2016 8:44 AM PDT

Infrared Sensor for the Detection of Alzheimer from Blood

WRITTEN BY: Xuan Pham
New patented diagnostic method for Alzheimer's detection

In the past several months, researchers have been focusing on easier point-of-care tests that offer early detection of diseases. One such test was recently proposed for Alzheimer’s disease, based on the idea of a portable biosensor that will diagnose disease progression by measuring beta-amyloid protein levels in the blood. However, such test has already been developed in Germany, and researchers recently reported 84 percent diagnostic precision from their first clinical trial.
 
The newly patented diagnostic test was developed by a research team at the Ruhr-University Bochum in Germany. Instead of just measuring levels of the beta-amyloid proteins, a signature of Alzheimer’s, the new test uses an infrared sensor that detects pathological misfolding of the protein. The presence of such misfolded proteins can occur more than 15 years before symptoms appear in the patients, and thus offer unprecedented early detection for the disease.
 
To assay beta-amyloid misfolding, the new test uses specific antibodies to attract protein biomarkers from cerebrospinal fluid samples or blood samples. The patent-pending infrared technology then scans the proteins for the presence and total distribution of secondary structures. Unlike other enzyme-linked immunosorbent assays (ELISA) that give the concentrations of abnormally folded proteins, the new test gives information on the distribution of the secondary structures, which could offer higher precision.
 
 "We do not merely select one single possible folding arrangement of the peptide; rather, we detect how all existing Amyloid beta secondary structures are distributed, in their healthy and in their pathological forms," said Klaus Gerwert, senior study author.
 
In a small clinical trial of 141 patients, the new test achieved a diagnostic precision of 84 percent in the blood and 90 per cent in cerebrospinal fluid. "What's unique about it is that this is the only robust label-free test with a single threshold," said Andreas Nabers, first study author.
 
Alzheimer’s disease is highly prevalent, accounting for over 7 million new cases every year. While there’s no cure yet, the detection and early diagnosis of the disease could influence patient care and outcome. According to the study authors, current diagnosis for the disease comes too late, as severe irreversible brain damages have already occurred in the time it takes for clinical symptoms to manifest. "If we wish to have a drug at our disposal that can significantly inhibit the progress of the disease, we need blood tests that detect Alzheimer's in its pre-dementia stages," said Gerwert. In catching Alzheimer early, researchers could have the rare opportunity to administer drugs to possibly prevent, or at the very least, delay its progression.
 

Additional source:  Ruhr-Universität Bochum press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 27, 2019
Health & Medicine
AUG 27, 2019
On the bright side, optimists may live longer
Do you see the glass half empty, or half full? If your answer is full, you may be in luck: Optimistic people live 11-15% longer than pessimists, according...
SEP 20, 2019
Neuroscience
SEP 20, 2019
The brain of a psychopath: how people with psychopathic traits control their 'dark urges'
Psychopaths are usually portrayed negatively: they display antisocial behavior, such as shallow emotions, callousness, impulsivity, and lack of empathy. Ps...
OCT 18, 2019
Health & Medicine
OCT 18, 2019
Are Washing Machines a Reservoir for Multidrug Resistant Pathogens?
Multidrug-resistant bacteria are frequently found in hospitals and long-term nursing facilities causing one of the largest public health concerns worldwide...
NOV 14, 2019
Cell & Molecular Biology
NOV 14, 2019
Scientists Find a Non-Invasive Way to Detect Prions
Misfolded proteins, also called prions, can cause a host of problems, including neurodegenerative disorders....
JAN 04, 2020
Immunology
JAN 04, 2020
Why Do Skincare Products Sometimes Cause Rashes?
Chemicals commonly found in skincare products are intended to avoid interactions with the part of the immune system responsible for triggering allergic inf...
JAN 11, 2020
Neuroscience
JAN 11, 2020
Molecular Therapy to Self-Repair Nerve Cells
Neurodegenerative diseases such as Multiple Sclerosis (MS), Alzheimer's, and Huntington's Disease are predicated on damage to myelin on nerve cells...
Loading Comments...